Literature DB >> 8606493

Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction.

J H Cho1, M Noguchi, A Ochiai, S Hirohashi.   

Abstract

Loss of heterozygosity (LOH) occurring on various chromosomes has been described in the majority of human tumors and its targets are believed to be tumor suppressor genes. Although allelic deletion of the p53 gene (over 60%) has been frequently observed in gastric cancer, as well as in other human malignancies, LOH of other tumor suppressor genes is still discrepant in gastric cancer. To our knowledge, simultaneous analysis of LOH using PCR in adenomatous polyposis coli (APC), deleted in colon cancer (DCC), and retinoblastoma susceptibility (Rb) genes has not yet been reported in sporadic gastric cancer. We examined 21 advanced gastric cancers (12 intestinal type and 9 diffuse type) for LOH at the APC, DCC, and Rb loci using PCR. Inclusion of these tumor suppressor genes in the allelic deletions was directly ascertained by performing PCR at polymorphic sites within the genes. LOH occurred in 30% of informative cases at APC, in 27% of informative cases at DCC, and in 30% of informative cases at Rb. Thirty-three percent of tumors informative at all loci (fully informative) lost heterozygosity at all three loci. There were no significant differences among histologic types in the prevalence of LOH at any locus and no correlations between losses involving APC, DCC, and Rb genes. These data suggest that inactivation of APC, DCC, and Rb is involved in the development and progression of some human gastric cancers regardless of histologic type.

Entities:  

Mesh:

Year:  1996        PMID: 8606493

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  6 in total

1.  Alteration of sister chromatid exchange frequencies in gastric cancer and chronic atrophic gastritis patients with and without H. pylori infection.

Authors:  Ali Karaman; Doğan Nasir Binici; Mehmet Eşref Kabalar; Hakan Dursun; Ali Kurt
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

2.  Role of genetic variants of deleted in colorectal carcinoma (DCC) polymorphisms and esophageal and gastric cancers risk in Kashmir Valley and meta-analysis.

Authors:  Manzoor Ahmad Malik; Annapurna Gupta; Showkat Ali Zargar; Balraj Mittal
Journal:  Tumour Biol       Date:  2013-06-14

3.  Genetic evolution of alpha fetoprotein producing gastric cancer.

Authors:  H Fujii; K Ichikawa; T Takagaki; Y Nakanishi; M Ikegami; S Hirose; T Shimoda
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

4.  Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers.

Authors:  T Goi; A Yamaguchi; G Nakagawara; T Urano; H Shiku; K Furukawa
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

5.  Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients.

Authors:  F Austrup; P Uciechowski; C Eder; B Böckmann; B Suchy; G Driesel; S Jäckel; I Kusiak; H J Grill; M Giesing
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

6.  APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis.

Authors:  Se-Hoon Hong; Won Jae Lee; Young Doo Kim; Hyunjoo Kim; Young-Jun Jeon; Bitna Lim; Dong-Hyung Cho; Won Do Heo; Doo-Hyun Yang; Chan-Young Kim; Han-Kwang Yang; Jin Kuk Yang; Yong-Keun Jung
Journal:  Oncotarget       Date:  2016-04-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.